Novel Cardiac biomarkers in Ischemic heart disease
Frontiers | Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs
Biomarkers in Routine Heart Failure Clinical Care
Rapid detection of cardiac troponin
Established and Emerging Roles of Biomarkers in Heart Failure | Circulation Research
Biomarkers in Acute Cardiac Disease: The Present and the Future - ScienceDirect
Frontiers | Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases
Frontiers | Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease | NEJM
Biomarkers in Heart Failure | NEJM
Cardiac marker - Wikipedia
C-Reactive Protein: A Clinical Marker in Cardiovascular Disease | SpringerLink
Cardiac Markers: Definition and Efficacy, Markers of Myocardial Necrosis and Ischemia, Acute Coronary Syndrome Testing Strategy
Heart Disease | The Nutrition Source | Harvard T.H. Chan School of Public Health
Main pathophysiological pathways involved in heart failure and their... | Download Scientific Diagram
C-Reactive Protein test to screen for heart disease: Why do we need another test? - Harvard Health
Role of Cardiac Biomarkers in Diagnosing Heart Attack
VIDAS ® Troponin I Ultra - Understanding Your Concerns | bioMérieux Clinical Diagnostics
Heart-type fatty acid binding protein (H-FABP): a diagnostic marker for early stage AMI and myocardial ischemia, with or without necrosis. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc.
Profiling of the plasma proteome across different stages of human heart failure | Nature Communications